Related Experiment Videos
Is ACTH a key to understanding anticonvulsant action?
1Department of Paediatric Neurology, Royal Hospital for Sick Children, Edinburgh, UK.
Developmental Medicine and Child Neurology
|March 7, 1998
Summary
Adrenocorticotrophin hormone (ACTH) effectively treated intractable childhood epilepsy, particularly when electroencephalograms (EEGs) indicated benzodiazepine sensitivity. This study explores ACTH
Area of Science:
- Pediatric Neurology
- Epileptology
- Endocrinology
Background:
- Adrenocorticotrophin hormone (ACTH) has a long-standing history of use as an anticonvulsant therapy.
- Intractable epilepsies in children present significant therapeutic challenges.
Purpose of the Study:
- To describe the efficacy of Adrenocorticotrophin hormone (ACTH) in a cohort of pediatric patients with treatment-resistant epilepsy.
- To investigate potential predictors of ACTH response in epilepsy management.
Main Methods:
- Retrospective analysis of 23 children diagnosed with intractable epilepsies.
- Evaluation of treatment outcomes correlated with electroencephalogram (EEG) findings, specifically benzodiazepine sensitivity.
Main Results:
- Adrenocorticotrophin hormone (ACTH) demonstrated anticonvulsant effects in the studied pediatric population.
- A significant correlation was observed between ACTH efficacy and the presence of benzodiazepine sensitivity on EEG.
Conclusions:
- Adrenocorticotrophin hormone (ACTH) is a viable treatment option for intractable childhood epilepsies.
- Benzodiazepine sensitivity on EEG may predict a positive response to ACTH therapy, guiding clinical decision-making.